Pharmacogenomics & Precision Psychiatry at AACAP Annual Meeting 2026
20 sessions on pharmacogenomics & precision psychiatry · October 26–31, 2026, Atlanta, GA. Compare pharmacogenomics & precision psychiatry at other meetings →
Monday, October 26
15:30–17:30 · Lecture · Clinical Perspectives
Focus on Clinically Relevant Pharmacokinetic and Pharmacodynamic Genes
Reviews the pharmacokinetic and pharmacodynamic genes most relevant to prescribing psychotropic medications for children and adolescents.
15:30–17:30 · Lecture · Clinical Perspectives
Recent Pharmacogenetic Data With a Focus on Antipsychotic Medications
Presents recent pharmacogenetic findings relating to antipsychotic medications in young patients.
15:30–17:30 · Lecture · Clinical Perspectives
Following the Evidence: Guidelines and Resources to Inform the Use of Pharmacogenomics in Antipsychotic Prescribing
Covers available guidelines and resources that help clinicians apply pharmacogenomic information when prescribing antipsychotics.
15:30–17:30 · Lecture · Clinical Perspectives
Integrating Pharmacogenetics Into Clinical Care
Discusses practical approaches to incorporating pharmacogenetic testing into routine child and adolescent psychiatric care.
16:00–18:00 · Lecture
From Diagnosis to Direction: How Autism Genetics is Reshaping Clinical Care
Reviews how advances in autism genetics are changing clinical practice.
Autism & Neurodevelopmental Disorders · Neuroscience & Mechanisms
Symposium · Clinical Perspectives
From Evidence to Practice: 2026 Update on Pharmacogenetic Guidance for the Child and Adolescent Psychiatric Provider
Lisa B. Namerow · Salma Malik · Jeffrey Robert Strawn · Laura B. Ramsey · Jeffrey R. Bishop
Annual update on pharmacogenetic testing guidance for pediatric psychiatric prescribing, from clinician-researchers including Jeffrey Strawn, Laura Ramsey, and Jeffrey Bishop.
Tuesday, October 27
08:00–10:00 · Lecture
Implementation of Genetic Testing to Improve Care of Individuals Diagnosed with Neurodevelopmental Disorders: Current Rates, Barriers, and Processes to Increase Use to Improve Clinical Prognostication
Discusses current rates of, barriers to, and ways to increase genetic testing in neurodevelopmental disorders.
08:00–10:00 · Lecture
Genetic Testing Practices and Diagnostic Outcomes in Catatonia With and Without Neurodevelopmental Disorders
Presents genetic testing practices and diagnostic yield in catatonia with and without neurodevelopmental disorders.
Lecture · Plenary Session
James C. Harris, MD, Developmental Neuropsychiatry Forum: Translational Frontiers in Autism: Advancing Discovery from Gene Pathways to Patients
Rana Elmaghraby · Suma Jacob · Alexandra L. Bey · Pankhuree Vandana · Natasha Marrus · Matthew State · Alison T. Singer
Matthew State presents how the identification of more than 100 high-confidence autism risk genes is being turned into therapeutic programs, with profound autism as a tractable starting point, while Alison Singer brings the family perspective on genetic testing and trial participation.
Autism & Neurodevelopmental Disorders · Neuroscience & Mechanisms · Drug Pipeline & Clinical Trials
Wednesday, October 28
10:30–12:30 · Lecture
Novel Individual-Level Neuroimaging Biomarkers Across the Early Psychosis Spectrum
A talk within a symposium on early-career research, addressing individual-level neuroimaging biomarkers across the early psychosis spectrum.
10:30–12:30 · Lecture
Speech-Based Biomarkers for Psychosis Risk States
A talk within a symposium on early-career research, covering the use of speech-based biomarkers to identify psychosis risk states.
Posters (3)
- Impact of Sertraline Pharmacokinetics and Pharmacodynamics on Adverse Effects and Treatment Efficacy in Pediatric Patients With Anxiety — Cynthia Mora Muñoz et al.
- Polygenic Risk and BMI Among Antipsychotic-Treated Youth — Samuel Palmer et al.
- Navigating Uncertainty: A Qualitative Study on the Familial Impact of Confronting Genetic Variants of Uncertain Significance — Nicholas S. Diab et al.
Thursday, October 29
11:30–13:30 · Symposium
Innovations in Brain- and Behavior-Based Biomarkers Across Development: From Early Risk Detection to Treatment Response in Neurodevelopmental Disorders
Rana Elmaghraby · Alexandra L. Bey · Suma Jacob · Natasha Marrus · Heather Marie Joseph
Symposium on brain- and behavior-based biomarkers in neurodevelopmental disorders, from early risk detection through treatment response.
Autism & Neurodevelopmental Disorders · Child & Adolescent · Neuroscience & Mechanisms
13:30–15:30 · Session
Autism Genetics in Clinical Context: Enhancing Diagnostic Clarity and Informing Multidisciplinary Treatment
Sarah Daniella Kevelson · Amandeep Jutla · Jeremy Veenstra-VanderWeele · Pankhuree Vandana
Case conference on using genetic testing in autistic patients with complex psychiatric presentations to clarify diagnosis and guide treatment. Participants review when to consider genetic consultation and discuss illustrative cases.
Posters (3)
- Subclinical EEG Abnormalities in Autism: An Underutilized Precision Medicine Tool to Target Neuroelectric Dysfunction and Improve Functional Outcomes in Children — Muhammad Yusuf et al.
- Underutilization of Genetic Testing in Intellectual and Developmental Disabilities: A Caregiver Survey of Referral Patterns, Attitudes, and Barriers to Care — Sugapradha Saravanan et al.
- Plasma Metabolomic Signatures and Their Association With Behavioral Phenotypes in Pediatric Autism — Yi-An Hung et al.
Friday, October 30
Posters (1)
- Ketamine for Depression in Adolescents: Exploring Metabolites as Predictors of Treatment Response in a Randomized Midazolam-Controlled Study — Jacob Lister et al.
Other topics at this meeting
Child & Adolescent 1361Autism & Neurodevelopmental Disorders 272Diverse & Underserved Populations 231Practice, Policy & Workforce 171Psychotherapy 166Education & Training 156Digital Psychiatry & AI 149Measurement-Based Care & Diagnosis 145ADHD 135Neuroscience & Mechanisms 124PTSD & Trauma 114Suicide & Self-Harm 110